Statement: The most common adverse event in the primary trial was skin infection. primary peritoneal clear cell adenocarcinoma is an extremely rare adenocarcinoma arising from the peritoneum. it is composed of malignant glandular epithelium containing clear cells.
Primary_evidence: Adverse Events 1:   Total: 14/41 (34.15%)   Anemia 1/41 (2.44%)   Febrile neutropenia 1/41 (2.44%)   Eye disorders - Other, Visual disturbance 1/41 (2.44%)   Abdominal pain 1/41 (2.44%)   Constipation 1/41 (2.44%)   Nausea 1/41 (2.44%)   Fever 1/41 (2.44%)   Pain 1/41 (2.44%)   Skin infection 2/41 (4.88%)   Alkaline phosphatase increased 1/41 (2.44%)   Aspartate aminotransferase increased 1/41 (2.44%)